Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Using new technology to achieve the ideal mammogram

Author: KC Young

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

It is well established that the ideal mammogram should have the optimal average film density, which depends on selecting the correct exposure. It also needs to have the optimal contrast. This is more difficult to ensure as it depends on the intrinsic breast contrast, the radiographic contrast and film contrast. The operator has control over the radiographic contrast, by adjusting the kV, target material and filter material used and modern machines provide the operator with a greater range of choices. The use of modern very high contrast mammographic films may affect the optimal choice of beam quality. …
Metadata
Title
Using new technology to achieve the ideal mammogram
Author
KC Young
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr225

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

How do radiographers compare to radiologists when double reading screening mammograms

Meeting abstract

The Swedish Two-County Trial 20-years on: updated mortality results and new insights from long-term follow-up

Meeting abstract

Lymph node diagnosis

Meeting abstract

Minimally invasive treatment of the breast

Meeting abstract

Implanted markers prior to neoadjuvant chemotherapy: preliminary report

Meeting abstract

Between four walls: what level of privacy do women want?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits